BUSINESS ACQUISITIONS (Narrative) (Details) - USD ($) $ in Thousands |
Dec. 04, 2025 |
Feb. 28, 2025 |
Jan. 07, 2025 |
Jul. 03, 2026 |
|---|---|---|---|---|
| Precision | ||||
| Business Combination [Line Items] | ||||
| Consideration transferred | $ 153,500 | |||
| Fair Value | 1,400 | |||
| Earnout payments (up to) | $ 5,000 | |||
| VSi | ||||
| Business Combination [Line Items] | ||||
| Consideration transferred | $ 24,000 | |||
| Fair Value | 1,100 | $ 0 | ||
| Earnout payments (up to) | 4,000 | 3,000 | ||
| Common stock with a fair value | $ 4,000 | |||
| Biocoat Incorporated | ||||
| Business Combination [Line Items] | ||||
| Consideration transferred | $ 15,000 | |||
| Fair Value | 7,000 | 7,000 | ||
| Earnout payments (up to) | $ 7,000 | $ 7,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|